Evidence map›Paper›PMID 23457156›Full record

ArticlePediatrics2013

Rapid adoption of Lactobacillus rhamnosus GG for acute gastroenteritis.

Michelle W Parker, Joshua K Schaffzin, Andrea Lo Vecchio, Connie Yau, Karen Vonderhaar, Amy Guiot, William B Brinkman, Christine M White, Jeffrey M Simmons, Wendy E Gerhardt and 2 more

Abstract read
In one paragraph

Article in Pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Probiotics in Disease Prevention and Treatment.Journal of clinical pharmacology · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Michelle W ParkerDivision of Hospital Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, MLC 3024, Cincinnati, OH 45229-3039, USA. michelle.parker@cchmc.org
Joshua K Schaffzin
Andrea Lo Vecchio
Connie Yau
Karen Vonderhaar
Amy Guiot
William B Brinkman
Christine M White
Jeffrey M Simmons
Wendy E Gerhardt
Uma R Kotagal
Patrick H Conway

Funding

Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2012 to 2014
$9.9M
Medication Continuity in Children Treated for ADHDK23MH083027 · NIMH · CINCINNATI CHILDRENS HOSP MED CTR · PI BRINKMAN, WILLIAM BERNARD · 2010 to 2014
$878k
NCATS NIH HHS UL1 TR000077NIMH NIH HHS K23 MH083027
6 · The paper itself

Abstract

BACKGROUND AND

objectivesA 2007 meta-analysis showed probiotics, specifically Lactobacillus rhamnosus GG (LGG), shorten diarrhea from acute gastroenteritis (AGE) by 24 hours and decrease risk of progression beyond 7 days. In 2005, our institution published a guideline recommending consideration of probiotics for patients with AGE, but only 1% of inpatients with AGE were prescribed LGG. The objective of this study was to increase inpatient prescribing of LGG at admission to >90%, for children hospitalized with AGE, within 120 days.

methodsThis quality improvement study included patients aged 2 months to 18 years admitted to general pediatrics with AGE with diarrhea. Diarrhea was defined as looser or ≥ 3 stools in the preceding 24 hours. Patients with complex medical conditions or with presumed bacterial gastroenteritis were excluded. Admitting and supervising clinicians were educated on the evidence. We ensured LGG was adequately stocked in our pharmacies and updated an AGE-specific computerized order set to include a default LGG order. Failure identification and mitigation were conducted via daily electronic chart review and e-mail communication. Primary outcome was the percentage of included patients prescribed LGG within 18 hours of admission. Intervention impact was assessed with run charts tracking our primary outcome over time.

resultsThe prescribing rate increased to 100% within 6 weeks and has been sustained for 7 months.

conclusionsKeys to success were pharmacy collaboration, use of an electronic medical record for a standardized order set, and rapid identification and mitigation of failures. Rapid implementation of evidence-based practices is possible using improvement science methods.

Indexed as

Diffusion of InnovationLacticaseibacillus rhamnosusAcute DiseaseAdolescentChildChild, PreschoolDiarrheaEvidence-Based MedicineGastroenteritisHospitals, PediatricHumansInfantMedical Order Entry SystemsOhioOrganizational InnovationPharmacy Service, Hospital

Identifiers

PMID23457156
PMCPMC4258826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.